U. Demirci Et Al. , "EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC)," 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.23, Vienna, Austria, pp.277, 2012
Demirci, U. Et Al. 2012. EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC). 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Vienna, Austria), 277.
Demirci, U., Yaman, M., Buyukberber, S., Ekinci, O., Ozkan, S., Coskun, U., ... Benekli, M.(2012). EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC) . 37th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.277). Vienna, Austria
Demirci, U. Et Al. "EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC)," 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 2012
Demirci, U. Et Al. "EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC)." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, pp.277, 2012
Demirci, U. Et Al. (2012) . "EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC)." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, p.277.
@conferencepaper{conferencepaper, author={U. Demirci Et Al. }, title={EXPRESSION AND CLINICAL IMPORTANCE OF E-CADHERIN, DYSADHERIN AND CHEMOKINE LIGAND 2 (CCL2) IN RENAL CELL CARCINOMA (RCC)}, congress name={37th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Vienna}, country={Austria}, year={2012}, pages={277} }